31 related articles for article (PubMed ID: 20716415)
1. [The relationship of expression of GLUT1,HIF-1α and the uptake of FDG in non-small cell lung cancer].
Ai B; Pan T; Zheng Z; Chen T
Zhongguo Fei Ai Za Zhi; 2007 Dec; 10(6):508-12. PubMed ID: 21129310
[TBL] [Abstract][Full Text] [Related]
2. FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer.
Chung JH; Lee WW; Park SY; Choe G; Sung SW; Chung JK; Lee MC; Kim SE
Eur J Surg Oncol; 2006 Nov; 32(9):989-95. PubMed ID: 16859874
[TBL] [Abstract][Full Text] [Related]
3. Correlation of Glut-1 glucose transporter expression with [(18)F]FDG uptake in non-small cell lung cancer.
Higashi K; Ueda Y; Sakurai A; Mingwang X; Xu L; Murakami M; Seki H; Oguchi M; Taki S; Nambu Y; Tonami H; Katsuda S; Yamamoto I
Eur J Nucl Med; 2000 Dec; 27(12):1778-85. PubMed ID: 24578007
[TBL] [Abstract][Full Text] [Related]
4. ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study.
Nakajo M; Kajiya Y; Tani A; Yoneda S; Shirahama H; Higashi M; Nakajo M
Eur J Radiol; 2012 Jan; 81(1):146-51. PubMed ID: 20810231
[TBL] [Abstract][Full Text] [Related]
5. The relationship between GLUT-1 and vascular endothelial growth factor expression and 18F-FDG uptake in esophageal squamous cell cancer patients.
Kobayashi M; Kaida H; Kawahara A; Hattori S; Kurata S; Hayakawa M; Hirose Y; Uchida M; Kage M; Fujita H; Hayabuchi N; Ishibashi M
Clin Nucl Med; 2012 May; 37(5):447-52. PubMed ID: 22475893
[TBL] [Abstract][Full Text] [Related]
6. 18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients.
Walter F; Federman N; Apichairuk W; Nelson S; Phelps ME; Allen-Auerbach M; Walter MA; Czernin J
Pediatr Hematol Oncol; 2011 Oct; 28(7):579-87. PubMed ID: 21936620
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between FDG PET /CT and the expression of glutl and ki-67 antigen in esophageal cancer].
Mu DB; Wang SP; Yang WF; Fu Z; Chen XX; Sun XR; Yu JM
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):30-3. PubMed ID: 17575690
[TBL] [Abstract][Full Text] [Related]
8. [Expression of GLUT1 protein and its relationship with uptake of FDG in non-small cell lung cancer tissues].
Wang K; Sun Y; Wang T
Zhongguo Fei Ai Za Zhi; 2002 Jun; 5(3):174-6. PubMed ID: 21324274
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between Glut-1, Glut-3 expression and fluorodeoxyglucose uptake in NSCLC and benign pulmonary lesion.].
Wu T; Pan T; Zheng Z; Chen T; Pan Y
Zhongguo Fei Ai Za Zhi; 2008 Aug; 11(4):555-8. PubMed ID: 20735969
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?
Biehl KJ; Kong FM; Dehdashti F; Jin JY; Mutic S; El Naqa I; Siegel BA; Bradley JD
J Nucl Med; 2006 Nov; 47(11):1808-12. PubMed ID: 17079814
[TBL] [Abstract][Full Text] [Related]
11. Indeterminate pleural metastasis on contrast-enhanced chest CT in non-small cell lung cancer: improved differential diagnosis with (18)F-FDG PET/CT.
Jung MY; Chong A; Seon HJ; Choi S; Kim YH; Shin SS; Kim JW; Bom HS
Ann Nucl Med; 2012 May; 26(4):327-36. PubMed ID: 22350956
[TBL] [Abstract][Full Text] [Related]
12. Expression of glucose transporter-1, hexokinase-II, proliferating cell nuclear antigen and survival of patients with pancreatic cancer.
Lyshchik A; Higashi T; Hara T; Nakamoto Y; Fujimoto K; Doi R; Imamura M; Saga T; Togashi K
Cancer Invest; 2007; 25(3):154-62. PubMed ID: 17530485
[TBL] [Abstract][Full Text] [Related]
13. A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction.
Nordström B; Strang P; Bergström R; Nilsson S; Tribukait B
Cancer; 1996 Nov; 78(9):1942-51. PubMed ID: 8909315
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.
Liao S; Penney BC; Zhang H; Suzuki K; Pu Y
Acad Radiol; 2012 Jan; 19(1):69-77. PubMed ID: 22142679
[TBL] [Abstract][Full Text] [Related]
15. The correlation of expression of VEGF and EGFR with SUV of (18)FDG-PET-CT in non-small cell lung cancer.
Liu X; Zhang H; Yu X; Song T; Huang P; Wang H; Song SA
Contemp Oncol (Pozn); 2014; 18(5):334-9. PubMed ID: 25477756
[TBL] [Abstract][Full Text] [Related]
16. [The relationship between the CT signs and p53 abnormal expression in peripheral lung cancer].
Liu X; Zhang W; Gao G
Zhongguo Fei Ai Za Zhi; 2002 Feb; 5(1):18-20. PubMed ID: 21315021
[TBL] [Abstract][Full Text] [Related]
17. [The Correlation between FDG PET/CT Imaging and Molecule Makers in Non-Small Cell Lung Cancer.].
Zhou M; Sun T; Xing X; Yang J
Zhongguo Fei Ai Za Zhi; 2009 Feb; 12(2):172-5. PubMed ID: 20716415
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional profiling of non-small cell lung cancer using 18F-FDG PET/CT and volume perfusion CT.
Sauter AW; Winterstein S; Spira D; Hetzel J; Schulze M; Mueller M; Pfannenberg C; Claussen CD; Klotz E; Hann von Weyhern C; Horger MS
J Nucl Med; 2012 Apr; 53(4):521-9. PubMed ID: 22414637
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
